Global Antimicrobial Susceptibility Test Market By Product (Manual Antimicrobial Susceptibility Testing Products, Automated Laboratory Instruments, Culture and Growth Media, and Consumables), By Type (Antibacterial Susceptibility Testing, Antifungal Susceptibility Testing, Antiparasitic Susceptibility Testing, Other Susceptibility Testing Types (slow-growing pathogens)), By Method (Etest Method, Disk Diffusion, Automated Susceptibility Testing Instruments, Agar Dilution, Broth Dilution, Genotyping Method, Others), By Application (Clinical Diagnostics, Drug Discovery and Development, Epidemiology, Other Applications), By End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research &Academic Institutes, and Clinical Research Organizations (CROs), By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
Industry Trends
Antimicrobial susceptibility test is performed in laboratories to determine the potential efficacy of various antibiotics on bacteria and/or whether bacteria has developed resistance to specific antibiotics, as well as for antifungal and antiviral species.The American Society for Treatment of Infectious Diseases (ASTID) aids in the evaluation of treatment services provided by hospitals, clinics, and national infection prevention and control programmes. During this technique/evaluation, bacterial, fungal, and viral strains are tested for susceptibility to a panel of antibiotics, antifungals, and antiviral medicines. The bacterium is exposed to a variety of antimicrobials, and the test evaluates whether it will grow in their presence. This information is presented to doctors in the form of a Minimum Inhibitory Concentration (MIC), which is a measure of a microorganism's sensitivity to or resistance to an antibiotic.Due to the rising prevalence of infectious disease epidemics such as Neisseria meningitides, Shigella, Neisseria gonorrhoeae, and Salmonella serotype typhi, which are primarily caused by a lack of water supply, inadequate sanitation, and unsanitary conditions, antimicrobial susceptibility testing kits are in high demand. As a result, medical practitioners have realised the value of performing antibiotic susceptibility tests (ASTs), which are now a necessary component of clinical microbiology laboratories and are projected to drive future antimicrobial susceptibility test market expansion.
In 2018, an estimated 484,000 incident instances of multidrug resistance/Rifampicin resistance were recorded in the United States, according to sources. More than half of these incidences occurredin India (27 % of cases), China (14% of cases), and the Russian Federation (12 % of cases). The ongoing global COVID-19 epidemic has impacted healthcare markets in a variety of ways, both favourably and negatively. While the world faced the COVID-19 epidemic, a major issue of antimicrobial resistance (AMR) received far less attention than it merited at the time. Prescribers used antibiotics indiscriminately to treat and prevent putative bacterial co-infections for the first six months of the outbreak because there was no confirmed therapy for COVID-19. There were shortcomings exposed in terms of appropriate antibiotic usage in the context of the pandemic, even in settings with well-established antimicrobial stewardship (AMS) programmes, which was of a major concern. Antimicrobial resistance (AMR) surveillance and antimicrobial resistance monitoring (AMS) have also been deprioritized as a result of the redirection of health-system resources to the pandemic response.From USD 3.2 billion in 2020 to USD 4.2 billion in 2025, the antimicrobial susceptibility test market is predicted to develop at a compound annual growth rate (CAGR) of 5.5% over the forecast period (2022 – 2030).
Global Antimicrobial Susceptibility Test Market Revenue & Forecast, (US$ Million), 2015 – 2030
Product Outlook
The antimicrobial susceptibility test market is segmented into product categories such as automated laboratory instruments, susceptibility testing discs, manual antimicrobial resistance test products, microbiological culture strips, culture and growth media, and consumables. For many years, manual susceptibility testing kits have dominated the antimicrobial susceptibility testing market. The development of antimicrobial resistance, the launch of new products, and the rising acceptance of susceptibility testing equipment in developing nations are all likely to boost the category.
Type Outlook
Antibacterial susceptibility testing was the most popular, accounting for the majority of the entire antimicrobial susceptibility test market in 2021. The vast majority of instances in this category of disease are caused by abuse of a broad-spectrum antibiotics, as well as the evolution of multidrug resistance. Overuse of broad-spectrum antibiotics can result in drug resistance in bacteria, necessitating the development of new drug screening tools.
Method Outlook
The automated antimicrobial susceptibility test equipment segment accounted for the largest share of the antimicrobial susceptibility test market among these approaches. The segment's revenue is primarily generated from its ability to provide qualitative and quantitative susceptibility data in a fast and accurate manner. Furthermore, technical improvements and increased R&D efforts by key competitors to provide the market with innovative techniques are accelerating the segment's expansion.
Application Outlook
Clinical diagnostics accounted for the majority of revenue of antimicrobial susceptibility test market. A large target patient population base (particularly in emerging markets), increasing procedural volume of clinical diagnostic tests, increasing emphasis on effective and early disease diagnosis across major markets, and the introduction of various technologically advanced susceptibility testing products are all factors that contribute to this segment's large share of the market.
End User Outlook
Antifungal test processes are being utilised in diagnostic laboratories and hospitals, as well as the expanding number of hospitals in major markets, are all contributing to the growth of the hospital category. In the coming decades, advances in healthcare infrastructure are projected to have an impact on the antimicrobial susceptibility test market. The installation and widespread use of increasingly complex, efficient, and sophisticated antibiotic susceptibility testing equipment and techniques at healthcare facilities all over the world has become possible as a result of growing government expenditures on healthcare.
Region Outlook
North America accounted for the lion's share of the antimicrobial susceptibility test market. However, the Asia-Pacific region is expected to grow at the fastest rate during the forecast period, owing to the rising incidence of infectious diseases, particularly in China and India, rising public awareness of one's own health and well-being, and the increasing use of over-the-counter antibiotics.
Competitive Analysis
The antimicrobial susceptibility testmarket’s competitive landscape provides information on each firm. Company overview, financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve, and more are all covered in this report. The information shown above is confined to the company's principal focus on the antimicrobial susceptibility testmarket, unless otherwise noted.
Key players profiled in the global antimicrobial susceptibility test market are listed below:
•Accelerate Diagnostics, Inc.
•Alifax S.r.l.
•Becton, Dickinson and Company
•Bioanalyse
•bioMérieux SA
•Bio-Rad Laboratories, Inc.
•Biotron Ltd
•Bruker
•CONDALAB
•Creative Diagnostics
•Danaher Corporation
•ELITechGroup
•Genefluidics, Inc.
•Hi-Media Laboratories
•InvivoGen
•Liofilchem S.r.l.
•Mast Group Ltd.
•Merck KGaA
•MP Biomedicals
•PML Microbiologicals Inc.
•QuantaMatrix Inc.
•Roche Diagnostics Limited
•Synbiosis
•Thermo Fisher Scientific
•ZHUHAI DL BIOTECH Co., Ltd.
•Other Market Participants
Global Antimicrobial Susceptibility Test Market:
By Product Outlook
•Manual Antimicrobial Susceptibility Testing Products
oSusceptibility Testing Disks
oMIC Strips
oSusceptibility Testing Plates
•Automated Laboratory Instruments
•Culture and Growth Media
•Consumables
By Type Outlook
•Antibacterial Susceptibility Testing
•Antifungal Susceptibility Testing
•Antiparasitic Susceptibility Testing
•Other Susceptibility Testing Types (slow-growing pathogens)
By Method Outlook
•Etest Method
•Disk Diffusion
•Automated Susceptibility Testing Instruments
•Agar Dilution
•Broth Dilution
•Genotyping Methods
•Others
By Application Outlook
•Clinical Diagnostics
•Drug Discovery and Development
•Epidemiology
•Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring)
By End User Outlook
•Hospitals and Diagnostic Centers
•Pharmaceutical and Biotechnology Companies
•Research &Academic Institutes
•Clinical Research Organizations (CROs)
By Region
•North America
oU.S.
oCanada
oMexico
oRest of North America
•Europe
oFrance
oThe UK
oSpain
oGermany
oItaly
oNordic Countries
Denmark
Finland
Iceland
Sweden
Norway
oBenelux Union
Belgium
The Netherlands
Luxembourg
oRest of Europe
•Asia Pacific
oChina
oJapan
oIndia
oNew Zealand
oAustralia
oSouth Korea
oSoutheast Asia
Indonesia
Thailand
Malaysia
Singapore
Rest of Southeast Asia
oRest of Asia Pacific
•Middle East & Africa
oSaudi Arabia
oUAE
oEgypt
oKuwait
oSouth Africa
oRest of Middle East & Africa
•Latin America
oBrazil
oArgentina
oRest of Latin America
Table of Contents 1. Market Scope 1.1. Market Segmentation 1.2. Years Considered 1.2.1. Historic Years: 2015 - 2020 1.2.2. Base Year: 2021 1.2.3. Forecast Years: 2022 – 2030 2. Key Target Audiences 3. Research Methodology 3.1. Primary Research 3.1.1. Research Questionnaire 3.1.2. Global Percentage Breakdown 3.1.3. Primary Interviews: Key Opinion Leaders (KOLs) 3.2. Secondary Research 3.2.1. Paid Databases 3.2.2. Secondary Sources 3.3. Market Size Estimates 3.3.1. Top-Down Approach 3.3.2. Bottom-Up Approach 3.4. Data Triangulation Methodology 3.5. Research Assumptions 4. Recommendations and Insights from AMI’s Perspective** 5. Holistic Overview of Antimicrobial Susceptibility Test Market 6. Market Synopsis: Antimicrobial Susceptibility Test Market 7. Antimicrobial Susceptibility Test Market Analysis: Qualitative Perspective 7.1. Introduction 7.1.1. Product Definition 7.1.2. Industry Development 7.2. Market Dynamics 7.2.1. Drivers 7.2.2. Restraints 7.2.3. Opportunities 7.2.4. Challenges 7.3. Trends in Antimicrobial Susceptibility Test Market 7.4. Market Determinants Radar Chart 7.5. Macro-Economic and Micro-Economic Indicators: Antimicrobial Susceptibility Test Market 7.6. Porter’s Five Force Analysis 7.7. Impact of Covid-19 on Antimicrobial Susceptibility Test Market 8. Global Antimicrobial Susceptibility Test Market Analysis and Forecasts, 2022 – 2030 8.1. Overview 8.1.1. Global Antimicrobial Susceptibility Test Market Revenue (US$ Mn) 8.2. Global Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Product 8.2.1. Manual Antimicrobial Susceptibility Testing (Definition, Market Estimation and Penetration, 2015 - 2021, Market Estimation (2015 - 2021), Market Forecast (2022 - 2030), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Susceptibility Testing Disks, MIC Strips, Susceptibility Testing Plates) 8.2.1.1. Susceptibility Testing Disks 8.2.1.2. MIC Strips 8.2.1.3. Susceptibility Testing Plates 8.2.2. Automated Antimicrobial Susceptibility Testing 8.2.2.1. Definition 8.2.2.2. Market Estimation and Penetration, 2015 - 2021 8.2.2.3. Market Forecast, 2022 - 2030 8.2.2.4. Compound Annual Growth Rate (CAGR) 8.2.2.5. Regional Bifurcation 8.2.2.5.1. North America 8.2.2.5.1.1. Market Estimation, 2015 - 2021 8.2.2.5.1.2. Market Forecast, 2022 - 2030 8.2.2.5.2. Europe 8.2.2.5.2.1. Market Estimation, 2015 - 2021 8.2.2.5.2.2. Market Forecast, 2022 - 2030 8.2.2.5.3. Asia Pacific 8.2.2.5.3.1. Market Estimation, 2015 - 2021 8.2.2.5.3.2. Market Forecast, 2022 - 2030 8.2.2.5.4. Middle East and Africa 8.2.2.5.4.1. Market Estimation, 2015 - 2021 8.2.2.5.4.2. Market Forecast, 2022 - 2030 8.2.2.5.5. Latin America 8.2.2.5.5.1. Market Estimation, 2015 - 2021 8.2.2.5.5.2. Market Forecast, 2022 - 2030 8.2.3. Culture and Growth Media 8.2.3.1. Definition 8.2.3.2. Market Estimation and Penetration, 2015 - 2021 8.2.3.3. Market Forecast, 2022 - 2030 8.2.3.4. Compound Annual Growth Rate (CAGR) 8.2.3.5. Regional Bifurcation 8.2.3.5.1. North America 8.2.3.5.1.1. Market Estimation, 2015 - 2021 8.2.3.5.1.2. Market Forecast, 2022 - 2030 8.2.3.5.2. Europe 8.2.3.5.2.1. Market Estimation, 2015 - 2021 8.2.3.5.2.2. Market Forecast, 2022 - 2030 8.2.3.5.3. Asia Pacific 8.2.3.5.3.1. Market Estimation, 2015 - 2021 8.2.3.5.3.2. Market Forecast, 2022 - 2030 8.2.3.5.4. Middle East and Africa 8.2.3.5.4.1. Market Estimation, 2015 - 2021 8.2.3.5.4.2. Market Forecast, 2022 - 2030 8.2.3.5.5. Latin America 8.2.3.5.5.1. Market Estimation, 2015 - 2021 8.2.3.5.5.2. Market Forecast, 2022 - 2030 8.2.4. Consumables 8.2.4.1. Definition 8.2.4.2. Market Estimation and Penetration, 2015 - 2021 8.2.4.3. Market Forecast, 2022 - 2030 8.2.4.4. Compound Annual Growth Rate (CAGR) 8.2.4.5. Regional Bifurcation 8.2.4.5.1. North America 8.2.4.5.1.1. Market Estimation, 2015 - 2021 8.2.4.5.1.2. Market Forecast, 2022 - 2030 8.2.4.5.2. Europe 8.2.4.5.2.1. Market Estimation, 2015 - 2021 8.2.4.5.2.2. Market Forecast, 2022 - 2030 8.2.4.5.3. Asia Pacific 8.2.4.5.3.1. Market Estimation, 2015 - 2021 8.2.4.5.3.2. Market Forecast, 2022 - 2030 8.2.4.5.4. Middle East and Africa 8.2.4.5.4.1. Market Estimation, 2015 - 2021 8.2.4.5.4.2. Market Forecast, 2022 - 2030 8.2.4.5.5. Latin America 8.2.4.5.5.1. Market Estimation, 2015 - 2021 8.2.4.5.5.2. Market Forecast, 2022 - 2030 8.3. Key Segment for Channeling Investments 8.3.1. By Product 9. Global Antimicrobial Susceptibility Test Market Analysis and Forecasts, 2022 – 2030 9.1. Overview 9.2. Global Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Type 9.2.1. Antibacterial Susceptibility Testing 9.2.1.1. Definition 9.2.1.2. Market Estimation and Penetration, 2015 - 2021 9.2.1.3. Market Forecast, 2022 - 2030 9.2.1.4. Compound Annual Growth Rate (CAGR) 9.2.1.5. Regional Bifurcation 9.2.1.5.1. North America 9.2.1.5.1.1. Market Estimation, 2015 - 2021 9.2.1.5.1.2. Market Forecast, 2022 - 2030 9.2.1.5.2. Europe 9.2.1.5.2.1. Market Estimation, 2015 - 2021 9.2.1.5.2.2. Market Forecast, 2022 - 2030 9.2.1.5.3. Asia Pacific 9.2.1.5.3.1. Market Estimation, 2015 - 2021 9.2.1.5.3.2. Market Forecast, 2022 - 2030 9.2.1.5.4. Middle East and Africa 9.2.1.5.4.1. Market Estimation, 2015 - 2021 9.2.1.5.4.2. Market Forecast, 2022 - 2030 9.2.1.5.5. Latin America 9.2.1.5.5.1. Market Estimation, 2015 - 2021 9.2.1.5.5.2. Market Forecast, 2022 - 2030 9.2.2. Antifungal Susceptibility Testing 9.2.2.1. Definition 9.2.2.2. Market Estimation and Penetration, 2015 - 2021 9.2.2.3. Market Forecast, 2022 - 2030 9.2.2.4. Compound Annual Growth Rate (CAGR) 9.2.2.5. Regional Bifurcation 9.2.2.5.1. North America 9.2.2.5.1.1. Market Estimation, 2015 - 2021 9.2.2.5.1.2. Market Forecast, 2022 - 2030 9.2.2.5.2. Europe 9.2.2.5.2.1. Market Estimation, 2015 - 2021 9.2.2.5.2.2. Market Forecast, 2022 - 2030 9.2.2.5.3. Asia Pacific 9.2.2.5.3.1. Market Estimation, 2015 - 2021 9.2.2.5.3.2. Market Forecast, 2022 - 2030 9.2.2.5.4. Middle East and Africa 9.2.2.5.4.1. Market Estimation, 2015 - 2021 9.2.2.5.4.2. Market Forecast, 2022 - 2030 9.2.2.5.5. Latin America 9.2.2.5.5.1. Market Estimation, 2015 - 2021 9.2.2.5.5.2. Market Forecast, 2022 - 2030 9.2.3. Antiparasitic Susceptibility Testing 9.2.3.1. Definition 9.2.3.2. Market Estimation and Penetration, 2015 - 2021 9.2.3.3. Market Forecast, 2022 - 2030 9.2.3.4. Compound Annual Growth Rate (CAGR) 9.2.3.5. Regional Bifurcation 9.2.3.5.1. North America 9.2.3.5.1.1. Market Estimation, 2015 - 2021 9.2.3.5.1.2. Market Forecast, 2022 - 2030 9.2.3.5.2. Europe 9.2.3.5.2.1. Market Estimation, 2015 - 2021 9.2.3.5.2.2. Market Forecast, 2022 - 2030 9.2.3.5.3. Asia Pacific 9.2.3.5.3.1. Market Estimation, 2015 - 2021 9.2.3.5.3.2. Market Forecast, 2022 - 2030 9.2.3.5.4. Middle East and Africa 9.2.3.5.4.1. Market Estimation, 2015 - 2021 9.2.3.5.4.2. Market Forecast, 2022 - 2030 9.2.3.5.5. Latin America 9.2.3.5.5.1. Market Estimation, 2015 - 2021 9.2.3.5.5.2. Market Forecast, 2022 - 2030 9.2.4. Other Susceptibility Testing Types (slow-growing pathogens) 9.2.4.1. Definition 9.2.4.2. Market Estimation and Penetration, 2015 - 2021 9.2.4.3. Market Forecast, 2022 - 2030 9.2.4.4. Compound Annual Growth Rate (CAGR) 9.2.4.5. Regional Bifurcation 9.2.4.5.1. North America 9.2.4.5.1.1. Market Estimation, 2015 - 2021 9.2.4.5.1.2. Market Forecast, 2022 - 2030 9.2.4.5.2. Europe 9.2.4.5.2.1. Market Estimation, 2015 - 2021 9.2.4.5.2.2. Market Forecast, 2022 - 2030 9.2.4.5.3. Asia Pacific 9.2.4.5.3.1. Market Estimation, 2015 - 2021 9.2.4.5.3.2. Market Forecast, 2022 - 2030 9.2.4.5.4. Middle East and Africa 9.2.4.5.4.1. Market Estimation, 2015 - 2021 9.2.4.5.4.2. Market Forecast, 2022 - 2030 9.2.4.5.5. Latin America 9.2.4.5.5.1. Market Estimation, 2015 - 2021 9.2.4.5.5.2. Market Forecast, 2022 - 2030 9.3. Key Segment for Channeling Investments 9.3.1. By Type 10. Global Antimicrobial Susceptibility Test Market Analysis and Forecasts, 2022 – 2030 10.1. Overview 10.2. Global Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Method 10.2.1. Etest Method 10.2.1.1. Definition 10.2.1.2. Market Estimation and Penetration, 2015 - 2021 10.2.1.3. Market Forecast, 2022 - 2030 10.2.1.4. Compound Annual Growth Rate (CAGR) 10.2.1.5. Regional Bifurcation 10.2.1.5.1. North America 10.2.1.5.1.1. Market Estimation, 2015 - 2021 10.2.1.5.1.2. Market Forecast, 2022 - 2030 10.2.1.5.2. Europe 10.2.1.5.2.1. Market Estimation, 2015 - 2021 10.2.1.5.2.2. Market Forecast, 2022 - 2030 10.2.1.5.3. Asia Pacific 10.2.1.5.3.1. Market Estimation, 2015 - 2021 10.2.1.5.3.2. Market Forecast, 2022 - 2030 10.2.1.5.4. Middle East and Africa 10.2.1.5.4.1. Market Estimation, 2015 - 2021 10.2.1.5.4.2. Market Forecast, 2022 - 2030 10.2.1.5.5. Latin America 10.2.1.5.5.1. Market Estimation, 2015 - 2021 10.2.1.5.5.2. Market Forecast, 2022 - 2030 10.2.2. Disk Diffusion 10.2.2.1. Definition 10.2.2.2. Market Estimation and Penetration, 2015 - 2021 10.2.2.3. Market Forecast, 2022 - 2030 10.2.2.4. Compound Annual Growth Rate (CAGR) 10.2.2.5. Regional Bifurcation 10.2.2.5.1. North America 10.2.2.5.1.1. Market Estimation, 2015 - 2021 10.2.2.5.1.2. Market Forecast, 2022 - 2030 10.2.2.5.2. Europe 10.2.2.5.2.1. Market Estimation, 2015 - 2021 10.2.2.5.2.2. Market Forecast, 2022 - 2030 10.2.2.5.3. Asia Pacific 10.2.2.5.3.1. Market Estimation, 2015 - 2021 10.2.2.5.3.2. Market Forecast, 2022 - 2030 10.2.2.5.4. Middle East and Africa 10.2.2.5.4.1. Market Estimation, 2015 - 2021 10.2.2.5.4.2. Market Forecast, 2022 - 2030 10.2.2.5.5. Latin America 10.2.2.5.5.1. Market Estimation, 2015 - 2021 10.2.2.5.5.2. Market Forecast, 2022 - 2030 10.2.3. Automated Susceptibility Testing Instruments 10.2.3.1. Definition 10.2.3.2. Market Estimation and Penetration, 2015 - 2021 10.2.3.3. Market Forecast, 2022 - 2030 10.2.3.4. Compound Annual Growth Rate (CAGR) 10.2.3.5. Regional Bifurcation 10.2.3.5.1. North America 10.2.3.5.1.1. Market Estimation, 2015 - 2021 10.2.3.5.1.2. Market Forecast, 2022 - 2030 10.2.3.5.2. Europe 10.2.3.5.2.1. Market Estimation, 2015 - 2021 10.2.3.5.2.2. Market Forecast, 2022 - 2030 10.2.3.5.3. Asia Pacific 10.2.3.5.3.1. Market Estimation, 2015 - 2021 10.2.3.5.3.2. Market Forecast, 2022 - 2030 10.2.3.5.4. Middle East and Africa 10.2.3.5.4.1. Market Estimation, 2015 - 2021 10.2.3.5.4.2. Market Forecast, 2022 - 2030 10.2.3.5.5. Latin America 10.2.3.5.5.1. Market Estimation, 2015 - 2021 10.2.3.5.5.2. Market Forecast, 2022 - 2030 10.2.4. Agar Dilution 10.2.4.1. Definition 10.2.4.2. Market Estimation and Penetration, 2015 - 2021 10.2.4.3. Market Forecast, 2022 - 2030 10.2.4.4. Compound Annual Growth Rate (CAGR) 10.2.4.5. Regional Bifurcation 10.2.4.5.1. North America 10.2.4.5.1.1. Market Estimation, 2015 - 2021 10.2.4.5.1.2. Market Forecast, 2022 - 2030 10.2.4.5.2. Europe 10.2.4.5.2.1. Market Estimation, 2015 - 2021 10.2.4.5.2.2. Market Forecast, 2022 - 2030 10.2.4.5.3. Asia Pacific 10.2.4.5.3.1. Market Estimation, 2015 - 2021 10.2.4.5.3.2. Market Forecast, 2022 - 2030 10.2.4.5.4. Middle East and Africa 10.2.4.5.4.1. Market Estimation, 2015 - 2021 10.2.4.5.4.2. Market Forecast, 2022 - 2030 10.2.4.5.5. Latin America 10.2.4.5.5.1. Market Estimation, 2015 - 2021 10.2.4.5.5.2. Market Forecast, 2022 - 2030 10.2.5. Broth Dilution 10.2.5.1. Definition 10.2.5.2. Market Estimation and Penetration, 2015 - 2021 10.2.5.3. Market Forecast, 2022 - 2030 10.2.5.4. Compound Annual Growth Rate (CAGR) 10.2.5.5. Regional Bifurcation 10.2.5.5.1. North America 10.2.5.5.1.1. Market Estimation, 2015 - 2021 10.2.5.5.1.2. Market Forecast, 2022 - 2030 10.2.5.5.2. Europe 10.2.5.5.2.1. Market Estimation, 2015 - 2021 10.2.5.5.2.2. Market Forecast, 2022 - 2030 10.2.5.5.3. Asia Pacific 10.2.5.5.3.1. Market Estimation, 2015 - 2021 10.2.5.5.3.2. Market Forecast, 2022 - 2030 10.2.5.5.4. Middle East and Africa 10.2.5.5.4.1. Market Estimation, 2015 - 2021 10.2.5.5.4.2. Market Forecast, 2022 - 2030 10.2.5.5.5. Latin America 10.2.5.5.5.1. Market Estimation, 2015 - 2021 10.2.5.5.5.2. Market Forecast, 2022 - 2030 10.2.6. Genotyping Method 10.2.6.1. Definition 10.2.6.2. Market Estimation and Penetration, 2015 - 2021 10.2.6.3. Market Forecast, 2022 - 2030 10.2.6.4. Compound Annual Growth Rate (CAGR) 10.2.6.5. Regional Bifurcation 10.2.6.5.1. North America 10.2.6.5.1.1. Market Estimation, 2015 - 2021 10.2.6.5.1.2. Market Forecast, 2022 - 2030 10.2.6.5.2. Europe 10.2.6.5.2.1. Market Estimation, 2015 - 2021 10.2.6.5.2.2. Market Forecast, 2022 - 2030 10.2.6.5.3. Asia Pacific 10.2.6.5.3.1. Market Estimation, 2015 - 2021 10.2.6.5.3.2. Market Forecast, 2022 - 2030 10.2.6.5.4. Middle East and Africa 10.2.6.5.4.1. Market Estimation, 2015 - 2021 10.2.6.5.4.2. Market Forecast, 2022 - 2030 10.2.6.5.5. Latin America 10.2.6.5.5.1. Market Estimation, 2015 - 2021 10.2.6.5.5.2. Market Forecast, 2022 - 2030 10.2.7. Others 10.2.7.1. Definition 10.2.7.2. Market Estimation and Penetration, 2015 - 2021 10.2.7.3. Market Forecast, 2022 - 2030 10.2.7.4. Compound Annual Growth Rate (CAGR) 10.2.7.5. Regional Bifurcation 10.2.7.5.1. North America 10.2.7.5.1.1. Market Estimation, 2015 - 2021 10.2.7.5.1.2. Market Forecast, 2022 - 2030 10.2.7.5.2. Europe 10.2.7.5.2.1. Market Estimation, 2015 - 2021 10.2.7.5.2.2. Market Forecast, 2022 - 2030 10.2.7.5.3. Asia Pacific 10.2.7.5.3.1. Market Estimation, 2015 - 2021 10.2.7.5.3.2. Market Forecast, 2022 - 2030 10.2.7.5.4. Middle East and Africa 10.2.7.5.4.1. Market Estimation, 2015 - 2021 10.2.7.5.4.2. Market Forecast, 2022 - 2030 10.2.7.5.5. Latin America 10.2.7.5.5.1. Market Estimation, 2015 - 2021 10.2.7.5.5.2. Market Forecast, 2022 - 2030 10.3. Key Segment for Channeling Investments 10.3.1. By Method 11. Global Antimicrobial Susceptibility Test Market Analysis and Forecasts, 2022 – 2030 11.1. Overview 11.2. Global Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Application 11.2.1. Clinical Diagnostics 11.2.1.1. Definition 11.2.1.2. Market Estimation and Penetration, 2015 - 2021 11.2.1.3. Market Forecast, 2022 - 2030 11.2.1.4. Compound Annual Growth Rate (CAGR) 11.2.1.5. Regional Bifurcation 11.2.1.5.1. North America 11.2.1.5.1.1. Market Estimation, 2015 - 2021 11.2.1.5.1.2. Market Forecast, 2022 - 2030 11.2.1.5.2. Europe 11.2.1.5.2.1. Market Estimation, 2015 - 2021 11.2.1.5.2.2. Market Forecast, 2022 - 2030 11.2.1.5.3. Asia Pacific 11.2.1.5.3.1. Market Estimation, 2015 - 2021 11.2.1.5.3.2. Market Forecast, 2022 - 2030 11.2.1.5.4. Middle East and Africa 11.2.1.5.4.1. Market Estimation, 2015 - 2021 11.2.1.5.4.2. Market Forecast, 2022 - 2030 11.2.1.5.5. Latin America 11.2.1.5.5.1. Market Estimation, 2015 - 2021 11.2.1.5.5.2. Market Forecast, 2022 - 2030 11.2.2. Drug Discovery and Development 11.2.2.1. Definition 11.2.2.2. Market Estimation and Penetration, 2015 - 2021 11.2.2.3. Market Forecast, 2022 - 2030 11.2.2.4. Compound Annual Growth Rate (CAGR) 11.2.2.5. Regional Bifurcation 11.2.2.5.1. North America 11.2.2.5.1.1. Market Estimation, 2015 - 2021 11.2.2.5.1.2. Market Forecast, 2022 - 2030 11.2.2.5.2. Europe 11.2.2.5.2.1. Market Estimation, 2015 - 2021 11.2.2.5.2.2. Market Forecast, 2022 - 2030 11.2.2.5.3. Asia Pacific 11.2.2.5.3.1. Market Estimation, 2015 - 2021 11.2.2.5.3.2. Market Forecast, 2022 - 2030 11.2.2.5.4. Middle East and Africa 11.2.2.5.4.1. Market Estimation, 2015 - 2021 11.2.2.5.4.2. Market Forecast, 2022 - 2030 11.2.2.5.5. Latin America 11.2.2.5.5.1. Market Estimation, 2015 - 2021 11.2.2.5.5.2. Market Forecast, 2022 - 2030 11.2.3. Epidemiology 11.2.3.1. Definition 11.2.3.2. Market Estimation and Penetration, 2015 - 2021 11.2.3.3. Market Forecast, 2022 - 2030 11.2.3.4. Compound Annual Growth Rate (CAGR) 11.2.3.5. Regional Bifurcation 11.2.3.5.1. North America 11.2.3.5.1.1. Market Estimation, 2015 - 2021 11.2.3.5.1.2. Market Forecast, 2022 - 2030 11.2.3.5.2. Europe 11.2.3.5.2.1. Market Estimation, 2015 - 2021 11.2.3.5.2.2. Market Forecast, 2022 - 2030 11.2.3.5.3. Asia Pacific 11.2.3.5.3.1. Market Estimation, 2015 - 2021 11.2.3.5.3.2. Market Forecast, 2022 - 2030 11.2.3.5.4. Middle East and Africa 11.2.3.5.4.1. Market Estimation, 2015 - 2021 11.2.3.5.4.2. Market Forecast, 2022 - 2030 11.2.3.5.5. Latin America 11.2.3.5.5.1. Market Estimation, 2015 - 2021 11.2.3.5.5.2. Market Forecast, 2022 - 2030 11.2.4. Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring) 11.2.4.1. Definition 11.2.4.2. Market Estimation and Penetration, 2015 - 2021 11.2.4.3. Market Forecast, 2022 - 2030 11.2.4.4. Compound Annual Growth Rate (CAGR) 11.2.4.5. Regional Bifurcation 11.2.4.5.1. North America 11.2.4.5.1.1. Market Estimation, 2015 - 2021 11.2.4.5.1.2. Market Forecast, 2022 - 2030 11.2.4.5.2. Europe 11.2.4.5.2.1. Market Estimation, 2015 - 2021 11.2.4.5.2.2. Market Forecast, 2022 - 2030 11.2.4.5.3. Asia Pacific 11.2.4.5.3.1. Market Estimation, 2015 - 2021 11.2.4.5.3.2. Market Forecast, 2022 - 2030 11.2.4.5.4. Middle East and Africa 11.2.4.5.4.1. Market Estimation, 2015 - 2021 11.2.4.5.4.2. Market Forecast, 2022 - 2030 11.2.4.5.5. Latin America 11.2.4.5.5.1. Market Estimation, 2015 - 2021 11.2.4.5.5.2. Market Forecast, 2022 - 2030 11.3. Key Segment for Channeling Investments 11.3.1. By Application 12. Global Antimicrobial Susceptibility Test Market Analysis and Forecasts, 2022 – 2030 12.1. Overview 12.2. Global Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By End User 12.2.1. Hospitals and Diagnostic Centers 12.2.1.1. Definition 12.2.1.2. Market Estimation and Penetration, 2015 - 2021 12.2.1.3. Market Forecast, 2022 - 2030 12.2.1.4. Compound Annual Growth Rate (CAGR) 12.2.1.5. Regional Bifurcation 12.2.1.5.1. North America 12.2.1.5.1.1. Market Estimation, 2015 - 2021 12.2.1.5.1.2. Market Forecast, 2022 - 2030 12.2.1.5.2. Europe 12.2.1.5.2.1. Market Estimation, 2015 - 2021 12.2.1.5.2.2. Market Forecast, 2022 - 2030 12.2.1.5.3. Asia Pacific 12.2.1.5.3.1. Market Estimation, 2015 - 2021 12.2.1.5.3.2. Market Forecast, 2022 - 2030 12.2.1.5.4. Middle East and Africa 12.2.1.5.4.1. Market Estimation, 2015 - 2021 12.2.1.5.4.2. Market Forecast, 2022 - 2030 12.2.1.5.5. Latin America 12.2.1.5.5.1. Market Estimation, 2015 - 2021 12.2.1.5.5.2. Market Forecast, 2022 - 2030 12.2.2. Pharmaceutical and Biotechnology Companies 12.2.2.1. Definition 12.2.2.2. Market Estimation and Penetration, 2015 - 2021 12.2.2.3. Market Forecast, 2022 - 2030 12.2.2.4. Compound Annual Growth Rate (CAGR) 12.2.2.5. Regional Bifurcation 12.2.2.5.1. North America 12.2.2.5.1.1. Market Estimation, 2015 - 2021 12.2.2.5.1.2. Market Forecast, 2022 - 2030 12.2.2.5.2. Europe 12.2.2.5.2.1. Market Estimation, 2015 - 2021 12.2.2.5.2.2. Market Forecast, 2022 - 2030 12.2.2.5.3. Asia Pacific 12.2.2.5.3.1. Market Estimation, 2015 - 2021 12.2.2.5.3.2. Market Forecast, 2022 - 2030 12.2.2.5.4. Middle East and Africa 12.2.2.5.4.1. Market Estimation, 2015 - 2021 12.2.2.5.4.2. Market Forecast, 2022 - 2030 12.2.2.5.5. Latin America 12.2.2.5.5.1. Market Estimation, 2015 - 2021 12.2.2.5.5.2. Market Forecast, 2022 - 2030 12.2.3. Research and Academic Institutes 12.2.3.1. Definition 12.2.3.2. Market Estimation and Penetration, 2015 - 2021 12.2.3.3. Market Forecast, 2022 - 2030 12.2.3.4. Compound Annual Growth Rate (CAGR) 12.2.3.5. Regional Bifurcation 12.2.3.5.1. North America 12.2.3.5.1.1. Market Estimation, 2015 - 2021 12.2.3.5.1.2. Market Forecast, 2022 - 2030 12.2.3.5.2. Europe 12.2.3.5.2.1. Market Estimation, 2015 - 2021 12.2.3.5.2.2. Market Forecast, 2022 - 2030 12.2.3.5.3. Asia Pacific 12.2.3.5.3.1. Market Estimation, 2015 - 2021 12.2.3.5.3.2. Market Forecast, 2022 - 2030 12.2.3.5.4. Middle East and Africa 12.2.3.5.4.1. Market Estimation, 2015 - 2021 12.2.3.5.4.2. Market Forecast, 2022 - 2030 12.2.3.5.5. Latin America 12.2.3.5.5.1. Market Estimation, 2015 - 2021 12.2.3.5.5.2. Market Forecast, 2022 - 2030 12.2.4. Clinical Research Organizations (CROs) 12.2.4.1. Definition 12.2.4.2. Market Estimation and Penetration, 2015 - 2021 12.2.4.3. Market Forecast, 2022 - 2030 12.2.4.4. Compound Annual Growth Rate (CAGR) 12.2.4.5. Regional Bifurcation 12.2.4.5.1. North America 12.2.4.5.1.1. Market Estimation, 2015 - 2021 12.2.4.5.1.2. Market Forecast, 2022 - 2030 12.2.4.5.2. Europe 12.2.4.5.2.1. Market Estimation, 2015 - 2021 12.2.4.5.2.2. Market Forecast, 2022 - 2030 12.2.4.5.3. Asia Pacific 12.2.4.5.3.1. Market Estimation, 2015 - 2021 12.2.4.5.3.2. Market Forecast, 2022 - 2030 12.2.4.5.4. Middle East and Africa 12.2.4.5.4.1. Market Estimation, 2015 - 2021 12.2.4.5.4.2. Market Forecast, 2022 - 2030 12.2.4.5.5. Latin America 12.2.4.5.5.1. Market Estimation, 2015 - 2021 12.2.4.5.5.2. Market Forecast, 2022 - 2030 12.3. Key Segment for Channeling Investments 12.3.1. By End User 13. North America Antimicrobial Susceptibility Test Market Analysis and Forecasts, 2022 - 2030 13.1. Overview 13.1.1. North America Antimicrobial Susceptibility Test Market Revenue (US$ Mn) 13.2. North America Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Product 13.2.1. Manual Antimicrobial Susceptibility Testing 13.2.1.1. Susceptibility Testing Disks 13.2.1.2. MIC Strips 13.2.1.3. Susceptibility Testing Plates 13.2.2. Automated Antimicrobial Susceptibility Testing 13.2.3. Culture and Growth Media 13.2.4. Consumables 13.3. North America Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Type 13.3.1. Antibacterial Susceptibility Testing 13.3.2. Antifungal Susceptibility Testing 13.3.3. Antiparasitic Susceptibility Testing 13.3.4. Other Susceptibility Testing Types (slow-growing pathogens) 13.4. North America Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Method 13.4.1. Etest Method 13.4.2. Disk Diffusion 13.4.3. Automated Susceptibility Testing Instruments 13.4.4. Agar Dilution 13.4.5. Broth Dilution 13.4.6. Genotyping Method 13.4.7. Others 13.5. North America Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Application 13.5.1. Clinical Diagnostics 13.5.2. Drug Discovery and Development 13.5.3. Epidemiology 13.5.4. Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring) 13.6. North America Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By End User 13.6.1. Hospitals and Diagnostic Centers 13.6.2. Pharmaceutical and Biotechnology Companies 13.6.3. Research and Academic Institutes 13.6.4. Clinical Research Organizations (CROs) 13.7. North America Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Country 13.7.1. U.S 13.7.1.1. U.S Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Product 13.7.1.1.1. Manual Antimicrobial Susceptibility Testing 13.7.1.1.1.1. Susceptibility Testing Disks 13.7.1.1.1.2. MIC Strips 13.7.1.1.1.3. Susceptibility Testing Plates 13.7.1.1.2. Automated Antimicrobial Susceptibility Testing 13.7.1.1.3. Culture and Growth Media 13.7.1.1.4. Consumables 13.7.1.2. U.S Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Type 13.7.1.2.1. Antibacterial Susceptibility Testing 13.7.1.2.2. Antifungal Susceptibility Testing 13.7.1.2.3. Antiparasitic Susceptibility Testing 13.7.1.2.4. Other Susceptibility Testing Types (slow-growing pathogens) 13.7.1.3. U.S Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Method 13.7.1.3.1. Etest Method 13.7.1.3.2. Disk Diffusion 13.7.1.3.3. Automated Susceptibility Testing Instruments 13.7.1.3.4. Agar Dilution 13.7.1.3.5. Broth Dilution 13.7.1.3.6. Genotyping Method 13.7.1.3.7. Others 13.7.1.4. U.S Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Application 13.7.1.4.1. Clinical Diagnostics 13.7.1.4.2. Drug Discovery and Development 13.7.1.4.3. Epidemiology 13.7.1.4.4. Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring) 13.7.1.5. U.S Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By End User 13.7.1.5.1. Hospitals and Diagnostic Centers 13.7.1.5.2. Pharmaceutical and Biotechnology Companies 13.7.1.5.3. Research and Academic Institutes 13.7.1.5.4. Clinical Research Organizations (CROs) 13.7.2. Canada 13.7.2.1. Canada Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Product 13.7.2.1.1. Manual Antimicrobial Susceptibility Testing 13.7.2.1.1.1. Susceptibility Testing Disks 13.7.2.1.1.2. MIC Strips 13.7.2.1.1.3. Susceptibility Testing Plates 13.7.2.1.2. Automated Antimicrobial Susceptibility Testing 13.7.2.1.3. Culture and Growth Media 13.7.2.1.4. Consumables 13.7.2.2. Canada Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Type 13.7.2.2.1. Antibacterial Susceptibility Testing 13.7.2.2.2. Antifungal Susceptibility Testing 13.7.2.2.3. Antiparasitic Susceptibility Testing 13.7.2.2.4. Other Susceptibility Testing Types (slow-growing pathogens) 13.7.2.3. Canada Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Method 13.7.2.3.1. Etest Method 13.7.2.3.2. Disk Diffusion 13.7.2.3.3. Automated Susceptibility Testing Instruments 13.7.2.3.4. Agar Dilution 13.7.2.3.5. Broth Dilution 13.7.2.3.6. Genotyping Method 13.7.2.3.7. Others 13.7.2.4. Canada Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Application 13.7.2.4.1. Clinical Diagnostics 13.7.2.4.2. Drug Discovery and Development 13.7.2.4.3. Epidemiology 13.7.2.4.4. Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring) 13.7.2.5. Canada Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By End User 13.7.2.5.1. Hospitals and Diagnostic Centers 13.7.2.5.2. Pharmaceutical and Biotechnology Companies 13.7.2.5.3. Research and Academic Institutes 13.7.2.5.4. Clinical Research Organizations (CROs) 13.7.3. Mexico 13.7.3.1. Mexico Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Product 13.7.3.1.1. Manual Antimicrobial Susceptibility Testing 13.7.3.1.1.1. Susceptibility Testing Disks 13.7.3.1.1.2. MIC Strips 13.7.3.1.1.3. Susceptibility Testing Plates 13.7.3.1.2. Automated Antimicrobial Susceptibility Testing 13.7.3.1.3. Culture and Growth Media 13.7.3.1.4. Consumables 13.7.3.2. Mexico Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Type 13.7.3.2.1. Antibacterial Susceptibility Testing 13.7.3.2.2. Antifungal Susceptibility Testing 13.7.3.2.3. Antiparasitic Susceptibility Testing 13.7.3.2.4. Other Susceptibility Testing Types (slow-growing pathogens) 13.7.3.3. Mexico Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Method 13.7.3.3.1. Etest Method 13.7.3.3.2. Disk Diffusion 13.7.3.3.3. Automated Susceptibility Testing Instruments 13.7.3.3.4. Agar Dilution 13.7.3.3.5. Broth Dilution 13.7.3.3.6. Genotyping Method 13.7.3.3.7. Others 13.7.3.4. Mexico Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Application 13.7.3.4.1. Clinical Diagnostics 13.7.3.4.2. Drug Discovery and Development 13.7.3.4.3. Epidemiology 13.7.3.4.4. Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring) 13.7.3.5. Mexico Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By End User 13.7.3.5.1. Hospitals and Diagnostic Centers 13.7.3.5.2. Pharmaceutical and Biotechnology Companies 13.7.3.5.3. Research and Academic Institutes 13.7.3.5.4. Clinical Research Organizations (CROs) 13.7.4. Rest of North America 13.7.4.1. Rest of North America Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Product 13.7.4.1.1. Manual Antimicrobial Susceptibility Testing 13.7.4.1.1.1. Susceptibility Testing Disks 13.7.4.1.1.2. MIC Strips 13.7.4.1.1.3. Susceptibility Testing Plates 13.7.4.1.2. Automated Antimicrobial Susceptibility Testing 13.7.4.1.3. Culture and Growth Media 13.7.4.1.4. Consumables 13.7.4.2. Rest of North America Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Type 13.7.4.2.1. Antibacterial Susceptibility Testing 13.7.4.2.2. Antifungal Susceptibility Testing 13.7.4.2.3. Antiparasitic Susceptibility Testing 13.7.4.2.4. Other Susceptibility Testing Types (slow-growing pathogens) 13.7.4.3. Rest of North America Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Method 13.7.4.3.1. Etest Method 13.7.4.3.2. Disk Diffusion 13.7.4.3.3. Automated Susceptibility Testing Instruments 13.7.4.3.4. Agar Dilution 13.7.4.3.5. Broth Dilution 13.7.4.3.6. Genotyping Method 13.7.4.3.7. Others 13.7.4.4. Rest of North America Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Application 13.7.4.4.1. Clinical Diagnostics 13.7.4.4.2. Drug Discovery and Development 13.7.4.4.3. Epidemiology 13.7.4.4.4. Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring) 13.7.4.5. Rest of North America Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By End User 13.7.4.5.1. Hospitals and Diagnostic Centers 13.7.4.5.2. Pharmaceutical and Biotechnology Companies 13.7.4.5.3. Research and Academic Institutes 13.7.4.5.4. Clinical Research Organizations (CROs) 13.8. Key Segment for Channeling Investments 13.8.1. By Country 13.8.2. By Product 13.8.3. By Type 13.8.4. By Method 13.8.5. By Application 13.8.6. By End User 14. Europe Antimicrobial Susceptibility Test Market Analysis and Forecasts, 2022 - 2030 14.1. Overview 14.1.1. Europe Antimicrobial Susceptibility Test Market Revenue (US$ Mn) 14.2. Europe Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Product 14.2.1. Manual Antimicrobial Susceptibility Testing 14.2.1.1. Susceptibility Testing Disks 14.2.1.2. MIC Strips 14.2.1.3. Susceptibility Testing Plates 14.2.2. Automated Antimicrobial Susceptibility Testing 14.2.3. Culture and Growth Media 14.2.4. Consumables 14.3. Europe Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Type 14.3.1. Antibacterial Susceptibility Testing 14.3.2. Antifungal Susceptibility Testing 14.3.3. Antiparasitic Susceptibility Testing 14.3.4. Other Susceptibility Testing Types (slow-growing pathogens) 14.4. Europe Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Method 14.4.1. Etest Method 14.4.2. Disk Diffusion 14.4.3. Automated Susceptibility Testing Instruments 14.4.4. Agar Dilution 14.4.5. Broth Dilution 14.4.6. Genotyping Method 14.4.7. Others 14.5. Europe Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Application 14.5.1. Clinical Diagnostics 14.5.2. Drug Discovery and Development 14.5.3. Epidemiology 14.5.4. Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring) 14.6. Europe Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By End User 14.6.1. Hospitals and Diagnostic Centers 14.6.2. Pharmaceutical and Biotechnology Companies 14.6.3. Research and Academic Institutes 14.6.4. Clinical Research Organizations (CROs) 14.7. Europe Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Country 14.7.1. France 14.7.1.1. France Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Product 14.7.1.1.1. Manual Antimicrobial Susceptibility Testing 14.7.1.1.1.1. Susceptibility Testing Disks 14.7.1.1.1.2. MIC Strips 14.7.1.1.1.3. Susceptibility Testing Plates 14.7.1.1.2. Automated Antimicrobial Susceptibility Testing 14.7.1.1.3. Culture and Growth Media 14.7.1.1.4. Consumables 14.7.1.2. France Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Type 14.7.1.2.1. Antibacterial Susceptibility Testing 14.7.1.2.2. Antifungal Susceptibility Testing 14.7.1.2.3. Antiparasitic Susceptibility Testing 14.7.1.2.4. Other Susceptibility Testing Types (slow-growing pathogens) 14.7.1.3. France Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Method 14.7.1.3.1. Etest Method 14.7.1.3.2. Disk Diffusion 14.7.1.3.3. Automated Susceptibility Testing Instruments 14.7.1.3.4. Agar Dilution 14.7.1.3.5. Broth Dilution 14.7.1.3.6. Genotyping Method 14.7.1.3.7. Others 14.7.1.4. France Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Application 14.7.1.4.1. Clinical Diagnostics 14.7.1.4.2. Drug Discovery and Development 14.7.1.4.3. Epidemiology 14.7.1.4.4. Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring) 14.7.1.5. France Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By End User 14.7.1.5.1. Hospitals and Diagnostic Centers 14.7.1.5.2. Pharmaceutical and Biotechnology Companies 14.7.1.5.3. Research and Academic Institutes 14.7.1.5.4. Clinical Research Organizations (CROs) 14.7.2. The UK 14.7.2.1. The UK Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Product 14.7.2.1.1. Manual Antimicrobial Susceptibility Testing 14.7.2.1.1.1. Susceptibility Testing Disks 14.7.2.1.1.2. MIC Strips 14.7.2.1.1.3. Susceptibility Testing Plates 14.7.2.1.2. Automated Antimicrobial Susceptibility Testing 14.7.2.1.3. Culture and Growth Media 14.7.2.1.4. Consumables 14.7.2.2. The UK Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Type 14.7.2.2.1. Antibacterial Susceptibility Testing 14.7.2.2.2. Antifungal Susceptibility Testing 14.7.2.2.3. Antiparasitic Susceptibility Testing 14.7.2.2.4. Other Susceptibility Testing Types (slow-growing pathogens) 14.7.2.3. The UK Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Method 14.7.2.3.1. Etest Method 14.7.2.3.2. Disk Diffusion 14.7.2.3.3. Automated Susceptibility Testing Instruments 14.7.2.3.4. Agar Dilution 14.7.2.3.5. Broth Dilution 14.7.2.3.6. Genotyping Method 14.7.2.3.7. Others 14.7.2.4. The UK Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Application 14.7.2.4.1. Clinical Diagnostics 14.7.2.4.2. Drug Discovery and Development 14.7.2.4.3. Epidemiology 14.7.2.4.4. Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring) 14.7.2.5. The UK Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By End User 14.7.2.5.1. Hospitals and Diagnostic Centers 14.7.2.5.2. Pharmaceutical and Biotechnology Companies 14.7.2.5.3. Research and Academic Institutes 14.7.2.5.4. Clinical Research Organizations (CROs) 14.7.3. Spain 14.7.3.1. Spain Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Product 14.7.3.1.1. Manual Antimicrobial Susceptibility Testing 14.7.3.1.1.1. Susceptibility Testing Disks 14.7.3.1.1.2. MIC Strips 14.7.3.1.1.3. Susceptibility Testing Plates 14.7.3.1.2. Automated Antimicrobial Susceptibility Testing 14.7.3.1.3. Culture and Growth Media 14.7.3.1.4. Consumables 14.7.3.2. Spain Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Type 14.7.3.2.1. Antibacterial Susceptibility Testing 14.7.3.2.2. Antifungal Susceptibility Testing 14.7.3.2.3. Antiparasitic Susceptibility Testing 14.7.3.2.4. Other Susceptibility Testing Types (slow-growing pathogens) 14.7.3.3. Spain Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Method 14.7.3.3.1. Etest Method 14.7.3.3.2. Disk Diffusion 14.7.3.3.3. Automated Susceptibility Testing Instruments 14.7.3.3.4. Agar Dilution 14.7.3.3.5. Broth Dilution 14.7.3.3.6. Genotyping Method 14.7.3.3.7. Others 14.7.3.4. Spain Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Application 14.7.3.4.1. Clinical Diagnostics 14.7.3.4.2. Drug Discovery and Development 14.7.3.4.3. Epidemiology 14.7.3.4.4. Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring) 14.7.3.5. Spain Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By End User 14.7.3.5.1. Hospitals and Diagnostic Centers 14.7.3.5.2. Pharmaceutical and Biotechnology Companies 14.7.3.5.3. Research and Academic Institutes 14.7.3.5.4. Clinical Research Organizations (CROs) 14.7.4. Germany 14.7.4.1. Germany Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Product 14.7.4.1.1. Manual Antimicrobial Susceptibility Testing 14.7.4.1.1.1. Susceptibility Testing Disks 14.7.4.1.1.2. MIC Strips 14.7.4.1.1.3. Susceptibility Testing Plates 14.7.4.1.2. Automated Antimicrobial Susceptibility Testing 14.7.4.1.3. Culture and Growth Media 14.7.4.1.4. Consumables 14.7.4.2. Germany Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Type 14.7.4.2.1. Antibacterial Susceptibility Testing 14.7.4.2.2. Antifungal Susceptibility Testing 14.7.4.2.3. Antiparasitic Susceptibility Testing 14.7.4.2.4. Other Susceptibility Testing Types (slow-growing pathogens) 14.7.4.3. Germany Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Method 14.7.4.3.1. Etest Method 14.7.4.3.2. Disk Diffusion 14.7.4.3.3. Automated Susceptibility Testing Instruments 14.7.4.3.4. Agar Dilution 14.7.4.3.5. Broth Dilution 14.7.4.3.6. Genotyping Method 14.7.4.3.7. Others 14.7.4.4. Germany Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Application 14.7.4.4.1. Clinical Diagnostics 14.7.4.4.2. Drug Discovery and Development 14.7.4.4.3. Epidemiology 14.7.4.4.4. Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring) 14.7.4.5. Germany Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By End User 14.7.4.5.1. Hospitals and Diagnostic Centers 14.7.4.5.2. Pharmaceutical and Biotechnology Companies 14.7.4.5.3. Research and Academic Institutes 14.7.4.5.4. Clinical Research Organizations (CROs) 14.7.5. Italy 14.7.5.1. Italy Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Product 14.7.5.1.1. Manual Antimicrobial Susceptibility Testing 14.7.5.1.1.1. Susceptibility Testing Disks 14.7.5.1.1.2. MIC Strips 14.7.5.1.1.3. Susceptibility Testing Plates 14.7.5.1.2. Automated Antimicrobial Susceptibility Testing 14.7.5.1.3. Culture and Growth Media 14.7.5.1.4. Consumables 14.7.5.2. Italy Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Type 14.7.5.2.1. Antibacterial Susceptibility Testing 14.7.5.2.2. Antifungal Susceptibility Testing 14.7.5.2.3. Antiparasitic Susceptibility Testing 14.7.5.2.4. Other Susceptibility Testing Types (slow-growing pathogens) 14.7.5.3. Italy Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Method 14.7.5.3.1. Etest Method 14.7.5.3.2. Disk Diffusion 14.7.5.3.3. Automated Susceptibility Testing Instruments 14.7.5.3.4. Agar Dilution 14.7.5.3.5. Broth Dilution 14.7.5.3.6. Genotyping Method 14.7.5.3.7. Others 14.7.5.4. Italy Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Application 14.7.5.4.1. Clinical Diagnostics 14.7.5.4.2. Drug Discovery and Development 14.7.5.4.3. Epidemiology 14.7.5.4.4. Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring) 14.7.5.5. Italy Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By End User 14.7.5.5.1. Hospitals and Diagnostic Centers 14.7.5.5.2. Pharmaceutical and Biotechnology Companies 14.7.5.5.3. Research and Academic Institutes 14.7.5.5.4. Clinical Research Organizations (CROs) 14.7.6. Nordic Countries 14.7.6.1. Nordic Countries Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Product 14.7.6.1.1. Manual Antimicrobial Susceptibility Testing 14.7.6.1.1.1. Susceptibility Testing Disks 14.7.6.1.1.2. MIC Strips 14.7.6.1.1.3. Susceptibility Testing Plates 14.7.6.1.2. Automated Antimicrobial Susceptibility Testing 14.7.6.1.3. Culture and Growth Media 14.7.6.1.4. Consumables 14.7.6.2. Nordic Countries Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Type 14.7.6.2.1. Antibacterial Susceptibility Testing 14.7.6.2.2. Antifungal Susceptibility Testing 14.7.6.2.3. Antiparasitic Susceptibility Testing 14.7.6.2.4. Other Susceptibility Testing Types (slow-growing pathogens) 14.7.6.3. Nordic Countries Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Method 14.7.6.3.1. Etest Method 14.7.6.3.2. Disk Diffusion 14.7.6.3.3. Automated Susceptibility Testing Instruments 14.7.6.3.4. Agar Dilution 14.7.6.3.5. Broth Dilution 14.7.6.3.6. Genotyping Method 14.7.6.3.7. Others 14.7.6.4. Nordic Countries Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Application 14.7.6.4.1. Clinical Diagnostics 14.7.6.4.2. Drug Discovery and Development 14.7.6.4.3. Epidemiology 14.7.6.4.4. Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring) 14.7.6.5. Nordic Countries Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By End User 14.7.6.5.1. Hospitals and Diagnostic Centers 14.7.6.5.2. Pharmaceutical and Biotechnology Companies 14.7.6.5.3. Research and Academic Institutes 14.7.6.5.4. Clinical Research Organizations (CROs) 14.7.6.6. Nordic Countries Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Country 14.7.6.6.1. Denmark 14.7.6.6.2. Finland 14.7.6.6.3. Iceland 14.7.6.6.4. Sweden 14.7.6.6.5. Norway 14.7.7. Benelux Union 14.7.7.1. Benelux Union Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Product 14.7.7.1.1. Manual Antimicrobial Susceptibility Testing 14.7.7.1.1.1. Susceptibility Testing Disks 14.7.7.1.1.2. MIC Strips 14.7.7.1.1.3. Susceptibility Testing Plates 14.7.7.1.2. Automated Antimicrobial Susceptibility Testing 14.7.7.1.3. Culture and Growth Media 14.7.7.1.4. Consumables 14.7.7.2. Benelux Union Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Type 14.7.7.2.1. Antibacterial Susceptibility Testing 14.7.7.2.2. Antifungal Susceptibility Testing 14.7.7.2.3. Antiparasitic Susceptibility Testing 14.7.7.2.4. Other Susceptibility Testing Types (slow-growing pathogens) 14.7.7.3. Benelux Union Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Method 14.7.7.3.1. Etest Method 14.7.7.3.2. Disk Diffusion 14.7.7.3.3. Automated Susceptibility Testing Instruments 14.7.7.3.4. Agar Dilution 14.7.7.3.5. Broth Dilution 14.7.7.3.6. Genotyping Method 14.7.7.3.7. Others 14.7.7.4. Benelux Union Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Application 14.7.7.4.1. Clinical Diagnostics 14.7.7.4.2. Drug Discovery and Development 14.7.7.4.3. Epidemiology 14.7.7.4.4. Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring) 14.7.7.5. Benelux Union Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By End User 14.7.7.5.1. Hospitals and Diagnostic Centers 14.7.7.5.2. Pharmaceutical and Biotechnology Companies 14.7.7.5.3. Research and Academic Institutes 14.7.7.5.4. Clinical Research Organizations (CROs) 14.7.7.6. Benelux Union Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Country 14.7.7.6.1. Belgium 14.7.7.6.2. The Netherlands 14.7.7.6.3. Luxembourg 14.7.8. Rest of Europe 14.7.8.1. Rest of Europe Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Product 14.7.8.1.1. Manual Antimicrobial Susceptibility Testing 14.7.8.1.1.1. Susceptibility Testing Disks 14.7.8.1.1.2. MIC Strips 14.7.8.1.1.3. Susceptibility Testing Plates 14.7.8.1.2. Automated Antimicrobial Susceptibility Testing 14.7.8.1.3. Culture and Growth Media 14.7.8.1.4. Consumables 14.7.8.2. Rest of Europe Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Type 14.7.8.2.1. Antibacterial Susceptibility Testing 14.7.8.2.2. Antifungal Susceptibility Testing 14.7.8.2.3. Antiparasitic Susceptibility Testing 14.7.8.2.4. Other Susceptibility Testing Types (slow-growing pathogens) 14.7.8.3. Rest of Europe Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Method 14.7.8.3.1. Etest Method 14.7.8.3.2. Disk Diffusion 14.7.8.3.3. Automated Susceptibility Testing Instruments 14.7.8.3.4. Agar Dilution 14.7.8.3.5. Broth Dilution 14.7.8.3.6. Genotyping Method 14.7.8.3.7. Others 14.7.8.4. Rest of Europe Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Application 14.7.8.4.1. Clinical Diagnostics 14.7.8.4.2. Drug Discovery and Development 14.7.8.4.3. Epidemiology 14.7.8.4.4. Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring) 14.7.8.5. Rest of Europe Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By End User 14.7.8.5.1. Hospitals and Diagnostic Centers 14.7.8.5.2. Pharmaceutical and Biotechnology Companies 14.7.8.5.3. Research and Academic Institutes 14.7.8.5.4. Clinical Research Organizations (CROs) 14.8. Key Segment for Channeling Investments 14.8.1. By Country 14.8.2. By Product 14.8.3. By Type 14.8.4. By Method 14.8.5. By Application 14.8.6. By End User 15. Asia Pacific Antimicrobial Susceptibility Test Market Analysis and Forecasts, 2022 - 2030 15.1. Overview 15.1.1. Asia Pacific Antimicrobial Susceptibility Test Market Revenue (US$ Mn) 15.2. Asia Pacific Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Product 15.2.1. Manual Antimicrobial Susceptibility Testing 15.2.1.1. Susceptibility Testing Disks 15.2.1.2. MIC Strips 15.2.1.3. Susceptibility Testing Plates 15.2.2. Automated Antimicrobial Susceptibility Testing 15.2.3. Culture and Growth Media 15.2.4. Consumables 15.3. Asia Pacific Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Type 15.3.1. Antibacterial Susceptibility Testing 15.3.2. Antifungal Susceptibility Testing 15.3.3. Antiparasitic Susceptibility Testing 15.3.4. Other Susceptibility Testing Types (slow-growing pathogens) 15.4. Asia Pacific Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Method 15.4.1. Etest Method 15.4.2. Disk Diffusion 15.4.3. Automated Susceptibility Testing Instruments 15.4.4. Agar Dilution 15.4.5. Broth Dilution 15.4.6. Genotyping Method 15.4.7. Others 15.5. Asia Pacific Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Application 15.5.1. Clinical Diagnostics 15.5.2. Drug Discovery and Development 15.5.3. Epidemiology 15.5.4. Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring) 15.6. Asia Pacific Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By End User 15.6.1. Hospitals and Diagnostic Centers 15.6.2. Pharmaceutical and Biotechnology Companies 15.6.3. Research and Academic Institutes 15.6.4. Clinical Research Organizations (CROs) 15.7. Asia Pacific Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Country 15.7.1. China 15.7.1.1. China Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Product 15.7.1.1.1. Manual Antimicrobial Susceptibility Testing 15.7.1.1.1.1. Susceptibility Testing Disks 15.7.1.1.1.2. MIC Strips 15.7.1.1.1.3. Susceptibility Testing Plates 15.7.1.1.2. Automated Antimicrobial Susceptibility Testing 15.7.1.1.3. Culture and Growth Media 15.7.1.1.4. Consumables 15.7.1.2. China Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Type 15.7.1.2.1. Antibacterial Susceptibility Testing 15.7.1.2.2. Antifungal Susceptibility Testing 15.7.1.2.3. Antiparasitic Susceptibility Testing 15.7.1.2.4. Other Susceptibility Testing Types (slow-growing pathogens) 15.7.1.3. China Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Method 15.7.1.3.1. Etest Method 15.7.1.3.2. Disk Diffusion 15.7.1.3.3. Automated Susceptibility Testing Instruments 15.7.1.3.4. Agar Dilution 15.7.1.3.5. Broth Dilution 15.7.1.3.6. Genotyping Method 15.7.1.3.7. Others 15.7.1.4. China Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Application 15.7.1.4.1. Clinical Diagnostics 15.7.1.4.2. Drug Discovery and Development 15.7.1.4.3. Epidemiology 15.7.1.4.4. Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring) 15.7.1.5. China Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By End User 15.7.1.5.1. Hospitals and Diagnostic Centers 15.7.1.5.2. Pharmaceutical and Biotechnology Companies 15.7.1.5.3. Research and Academic Institutes 15.7.1.5.4. Clinical Research Organizations (CROs) 15.7.2. Japan 15.7.2.1. Japan Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Product 15.7.2.1.1. Manual Antimicrobial Susceptibility Testing 15.7.2.1.1.1. Susceptibility Testing Disks 15.7.2.1.1.2. MIC Strips 15.7.2.1.1.3. Susceptibility Testing Plates 15.7.2.1.2. Automated Antimicrobial Susceptibility Testing 15.7.2.1.3. Culture and Growth Media 15.7.2.1.4. Consumables 15.7.2.2. Japan Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Type 15.7.2.2.1. Antibacterial Susceptibility Testing 15.7.2.2.2. Antifungal Susceptibility Testing 15.7.2.2.3. Antiparasitic Susceptibility Testing 15.7.2.2.4. Other Susceptibility Testing Types (slow-growing pathogens) 15.7.2.3. Japan Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Method 15.7.2.3.1. Etest Method 15.7.2.3.2. Disk Diffusion 15.7.2.3.3. Automated Susceptibility Testing Instruments 15.7.2.3.4. Agar Dilution 15.7.2.3.5. Broth Dilution 15.7.2.3.6. Genotyping Method 15.7.2.3.7. Others 15.7.2.4. Japan Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Application 15.7.2.4.1. Clinical Diagnostics 15.7.2.4.2. Drug Discovery and Development 15.7.2.4.3. Epidemiology 15.7.2.4.4. Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring) 15.7.2.5. Japan Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By End User 15.7.2.5.1. Hospitals and Diagnostic Centers 15.7.2.5.2. Pharmaceutical and Biotechnology Companies 15.7.2.5.3. Research and Academic Institutes 15.7.2.5.4. Clinical Research Organizations (CROs) 15.7.3. India 15.7.3.1. India Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Product 15.7.3.1.1. Manual Antimicrobial Susceptibility Testing 15.7.3.1.1.1. Susceptibility Testing Disks 15.7.3.1.1.2. MIC Strips 15.7.3.1.1.3. Susceptibility Testing Plates 15.7.3.1.2. Automated Antimicrobial Susceptibility Testing 15.7.3.1.3. Culture and Growth Media 15.7.3.1.4. Consumables 15.7.3.2. India Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Type 15.7.3.2.1. Antibacterial Susceptibility Testing 15.7.3.2.2. Antifungal Susceptibility Testing 15.7.3.2.3. Antiparasitic Susceptibility Testing 15.7.3.2.4. Other Susceptibility Testing Types (slow-growing pathogens) 15.7.3.3. India Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Method 15.7.3.3.1. Etest Method 15.7.3.3.2. Disk Diffusion 15.7.3.3.3. Automated Susceptibility Testing Instruments 15.7.3.3.4. Agar Dilution 15.7.3.3.5. Broth Dilution 15.7.3.3.6. Genotyping Method 15.7.3.3.7. Others 15.7.3.4. India Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Application 15.7.3.4.1. Clinical Diagnostics 15.7.3.4.2. Drug Discovery and Development 15.7.3.4.3. Epidemiology 15.7.3.4.4. Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring) 15.7.3.5. India Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By End User 15.7.3.5.1. Hospitals and Diagnostic Centers 15.7.3.5.2. Pharmaceutical and Biotechnology Companies 15.7.3.5.3. Research and Academic Institutes 15.7.3.5.4. Clinical Research Organizations (CROs) 15.7.4. New Zealand 15.7.4.1. New Zealand Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Product 15.7.4.1.1. Manual Antimicrobial Susceptibility Testing 15.7.4.1.1.1. Susceptibility Testing Disks 15.7.4.1.1.2. MIC Strips 15.7.4.1.1.3. Susceptibility Testing Plates 15.7.4.1.2. Automated Antimicrobial Susceptibility Testing 15.7.4.1.3. Culture and Growth Media 15.7.4.1.4. Consumables 15.7.4.2. New Zealand Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Type 15.7.4.2.1. Antibacterial Susceptibility Testing 15.7.4.2.2. Antifungal Susceptibility Testing 15.7.4.2.3. Antiparasitic Susceptibility Testing 15.7.4.2.4. Other Susceptibility Testing Types (slow-growing pathogens) 15.7.4.3. New Zealand Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Method 15.7.4.3.1. Etest Method 15.7.4.3.2. Disk Diffusion 15.7.4.3.3. Automated Susceptibility Testing Instruments 15.7.4.3.4. Agar Dilution 15.7.4.3.5. Broth Dilution 15.7.4.3.6. Genotyping Method 15.7.4.3.7. Others 15.7.4.4. New Zealand Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Application 15.7.4.4.1. Clinical Diagnostics 15.7.4.4.2. Drug Discovery and Development 15.7.4.4.3. Epidemiology 15.7.4.4.4. Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring) 15.7.4.5. New Zealand Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By End User 15.7.4.5.1. Hospitals and Diagnostic Centers 15.7.4.5.2. Pharmaceutical and Biotechnology Companies 15.7.4.5.3. Research and Academic Institutes 15.7.4.5.4. Clinical Research Organizations (CROs) 15.7.5. Australia 15.7.5.1. Australia Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Product 15.7.5.1.1. Manual Antimicrobial Susceptibility Testing 15.7.5.1.1.1. Susceptibility Testing Disks 15.7.5.1.1.2. MIC Strips 15.7.5.1.1.3. Susceptibility Testing Plates 15.7.5.1.2. Automated Antimicrobial Susceptibility Testing 15.7.5.1.3. Culture and Growth Media 15.7.5.1.4. Consumables 15.7.5.2. Australia Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Type 15.7.5.2.1. Antibacterial Susceptibility Testing 15.7.5.2.2. Antifungal Susceptibility Testing 15.7.5.2.3. Antiparasitic Susceptibility Testing 15.7.5.2.4. Other Susceptibility Testing Types (slow-growing pathogens) 15.7.5.3. Australia Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Method 15.7.5.3.1. Etest Method 15.7.5.3.2. Disk Diffusion 15.7.5.3.3. Automated Susceptibility Testing Instruments 15.7.5.3.4. Agar Dilution 15.7.5.3.5. Broth Dilution 15.7.5.3.6. Genotyping Method 15.7.5.3.7. Others 15.7.5.4. Australia Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Application 15.7.5.4.1. Clinical Diagnostics 15.7.5.4.2. Drug Discovery and Development 15.7.5.4.3. Epidemiology 15.7.5.4.4. Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring) 15.7.5.5. Australia Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By End User 15.7.5.5.1. Hospitals and Diagnostic Centers 15.7.5.5.2. Pharmaceutical and Biotechnology Companies 15.7.5.5.3. Research and Academic Institutes 15.7.5.5.4. Clinical Research Organizations (CROs) 15.7.6. South Korea 15.7.6.1. South Korea Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Product 15.7.6.1.1. Manual Antimicrobial Susceptibility Testing 15.7.6.1.1.1. Susceptibility Testing Disks 15.7.6.1.1.2. MIC Strips 15.7.6.1.1.3. Susceptibility Testing Plates 15.7.6.1.2. Automated Antimicrobial Susceptibility Testing 15.7.6.1.3. Culture and Growth Media 15.7.6.1.4. Consumables 15.7.6.2. South Korea Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Type 15.7.6.2.1. Antibacterial Susceptibility Testing 15.7.6.2.2. Antifungal Susceptibility Testing 15.7.6.2.3. Antiparasitic Susceptibility Testing 15.7.6.2.4. Other Susceptibility Testing Types (slow-growing pathogens) 15.7.6.3. South Korea Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Method 15.7.6.3.1. Etest Method 15.7.6.3.2. Disk Diffusion 15.7.6.3.3. Automated Susceptibility Testing Instruments 15.7.6.3.4. Agar Dilution 15.7.6.3.5. Broth Dilution 15.7.6.3.6. Genotyping Method 15.7.6.3.7. Others 15.7.6.4. South Korea Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Application 15.7.6.4.1. Clinical Diagnostics 15.7.6.4.2. Drug Discovery and Development 15.7.6.4.3. Epidemiology 15.7.6.4.4. Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring) 15.7.6.5. South Korea Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By End User 15.7.6.5.1. Hospitals and Diagnostic Centers 15.7.6.5.2. Pharmaceutical and Biotechnology Companies 15.7.6.5.3. Research and Academic Institutes 15.7.6.5.4. Clinical Research Organizations (CROs) 15.7.7. Southeast Asia 15.7.7.1. Southeast Asia Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Product 15.7.7.1.1. Manual Antimicrobial Susceptibility Testing 15.7.7.1.1.1. Susceptibility Testing Disks 15.7.7.1.1.2. MIC Strips 15.7.7.1.1.3. Susceptibility Testing Plates 15.7.7.1.2. Automated Antimicrobial Susceptibility Testing 15.7.7.1.3. Culture and Growth Media 15.7.7.1.4. Consumables 15.7.7.2. Southeast Asia Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Type 15.7.7.2.1. Antibacterial Susceptibility Testing 15.7.7.2.2. Antifungal Susceptibility Testing 15.7.7.2.3. Antiparasitic Susceptibility Testing 15.7.7.2.4. Other Susceptibility Testing Types (slow-growing pathogens) 15.7.7.3. Southeast Asia Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Method 15.7.7.3.1. Etest Method 15.7.7.3.2. Disk Diffusion 15.7.7.3.3. Automated Susceptibility Testing Instruments 15.7.7.3.4. Agar Dilution 15.7.7.3.5. Broth Dilution 15.7.7.3.6. Genotyping Method 15.7.7.3.7. Others 15.7.7.4. Southeast Asia Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Application 15.7.7.4.1. Clinical Diagnostics 15.7.7.4.2. Drug Discovery and Development 15.7.7.4.3. Epidemiology 15.7.7.4.4. Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring) 15.7.7.5. Southeast Asia Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By End User 15.7.7.5.1. Hospitals and Diagnostic Centers 15.7.7.5.2. Pharmaceutical and Biotechnology Companies 15.7.7.5.3. Research and Academic Institutes 15.7.7.5.4. Clinical Research Organizations (CROs) 15.7.7.6. Southeast Asia Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Country 15.7.7.6.1. Indonesia 15.7.7.6.2. Thailand 15.7.7.6.3. Malaysia 15.7.7.6.4. Singapore 15.7.7.6.5. Rest of Southeast Asia 15.7.8. Rest of Asia Pacific 15.7.8.1. Rest of Asia Pacific Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Product 15.7.8.1.1. Manual Antimicrobial Susceptibility Testing 15.7.8.1.1.1. Susceptibility Testing Disks 15.7.8.1.1.2. MIC Strips 15.7.8.1.1.3. Susceptibility Testing Plates 15.7.8.1.2. Automated Antimicrobial Susceptibility Testing 15.7.8.1.3. Culture and Growth Media 15.7.8.1.4. Consumables 15.7.8.2. Rest of Asia Pacific Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Type 15.7.8.2.1. Antibacterial Susceptibility Testing 15.7.8.2.2. Antifungal Susceptibility Testing 15.7.8.2.3. Antiparasitic Susceptibility Testing 15.7.8.2.4. Other Susceptibility Testing Types (slow-growing pathogens) 15.7.8.3. Rest of Asia Pacific Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Method 15.7.8.3.1. Etest Method 15.7.8.3.2. Disk Diffusion 15.7.8.3.3. Automated Susceptibility Testing Instruments 15.7.8.3.4. Agar Dilution 15.7.8.3.5. Broth Dilution 15.7.8.3.6. Genotyping Method 15.7.8.3.7. Others 15.7.8.4. Rest of Asia Pacific Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Application 15.7.8.4.1. Clinical Diagnostics 15.7.8.4.2. Drug Discovery and Development 15.7.8.4.3. Epidemiology 15.7.8.4.4. Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring) 15.7.8.5. Rest of Asia Pacific Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By End User 15.7.8.5.1. Hospitals and Diagnostic Centers 15.7.8.5.2. Pharmaceutical and Biotechnology Companies 15.7.8.5.3. Research and Academic Institutes 15.7.8.5.4. Clinical Research Organizations (CROs) 15.8. Key Segment for Channeling Investments 15.8.1. By Country 15.8.2. By Product 15.8.3. By Type 15.8.4. By Method 15.8.5. By Application 15.8.6. By End User 16. Middle East and Africa Antimicrobial Susceptibility Test Market Analysis and Forecasts, 2022 - 2030 16.1. Overview 16.1.1. Middle East and Africa Antimicrobial Susceptibility Test Market Revenue (US$ Mn) 16.2. Middle East and Africa Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Product 16.2.1. Manual Antimicrobial Susceptibility Testing 16.2.1.1. Susceptibility Testing Disks 16.2.1.2. MIC Strips 16.2.1.3. Susceptibility Testing Plates 16.2.2. Automated Antimicrobial Susceptibility Testing 16.2.3. Culture and Growth Media 16.2.4. Consumables 16.3. Middle East and Africa Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Type 16.3.1. Antibacterial Susceptibility Testing 16.3.2. Antifungal Susceptibility Testing 16.3.3. Antiparasitic Susceptibility Testing 16.3.4. Other Susceptibility Testing Types (slow-growing pathogens) 16.4. Middle East and Africa Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Method 16.4.1. Etest Method 16.4.2. Disk Diffusion 16.4.3. Automated Susceptibility Testing Instruments 16.4.4. Agar Dilution 16.4.5. Broth Dilution 16.4.6. Genotyping Method 16.4.7. Others 16.5. Middle East and Africa Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Application 16.5.1. Clinical Diagnostics 16.5.2. Drug Discovery and Development 16.5.3. Epidemiology 16.5.4. Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring) 16.6. Middle East and Africa Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By End User 16.6.1. Hospitals and Diagnostic Centers 16.6.2. Pharmaceutical and Biotechnology Companies 16.6.3. Research and Academic Institutes 16.6.4. Clinical Research Organizations (CROs) 16.7. Middle East and Africa Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Country 16.7.1. Saudi Arabia 16.7.1.1. Saudi Arabia Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Product 16.7.1.1.1. Manual Antimicrobial Susceptibility Testing 16.7.1.1.1.1. Susceptibility Testing Disks 16.7.1.1.1.2. MIC Strips 16.7.1.1.1.3. Susceptibility Testing Plates 16.7.1.1.2. Automated Antimicrobial Susceptibility Testing 16.7.1.1.3. Culture and Growth Media 16.7.1.1.4. Consumables 16.7.1.2. Saudi Arabia Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Type 16.7.1.2.1. Antibacterial Susceptibility Testing 16.7.1.2.2. Antifungal Susceptibility Testing 16.7.1.2.3. Antiparasitic Susceptibility Testing 16.7.1.2.4. Other Susceptibility Testing Types (slow-growing pathogens) 16.7.1.3. Saudi Arabia Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Method 16.7.1.3.1. Etest Method 16.7.1.3.2. Disk Diffusion 16.7.1.3.3. Automated Susceptibility Testing Instruments 16.7.1.3.4. Agar Dilution 16.7.1.3.5. Broth Dilution 16.7.1.3.6. Genotyping Method 16.7.1.3.7. Others 16.7.1.4. Saudi Arabia Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Application 16.7.1.4.1. Clinical Diagnostics 16.7.1.4.2. Drug Discovery and Development 16.7.1.4.3. Epidemiology 16.7.1.4.4. Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring) 16.7.1.5. Saudi Arabia Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By End User 16.7.1.5.1. Hospitals and Diagnostic Centers 16.7.1.5.2. Pharmaceutical and Biotechnology Companies 16.7.1.5.3. Research and Academic Institutes 16.7.1.5.4. Clinical Research Organizations (CROs) 16.7.2. UAE 16.7.2.1. UAE Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Product 16.7.2.1.1. Manual Antimicrobial Susceptibility Testing 16.7.2.1.1.1. Susceptibility Testing Disks 16.7.2.1.1.2. MIC Strips 16.7.2.1.1.3. Susceptibility Testing Plates 16.7.2.1.2. Automated Antimicrobial Susceptibility Testing 16.7.2.1.3. Culture and Growth Media 16.7.2.1.4. Consumables 16.7.2.2. UAE Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Type 16.7.2.2.1. Antibacterial Susceptibility Testing 16.7.2.2.2. Antifungal Susceptibility Testing 16.7.2.2.3. Antiparasitic Susceptibility Testing 16.7.2.2.4. Other Susceptibility Testing Types (slow-growing pathogens) 16.7.2.3. UAE Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Method 16.7.2.3.1. Etest Method 16.7.2.3.2. Disk Diffusion 16.7.2.3.3. Automated Susceptibility Testing Instruments 16.7.2.3.4. Agar Dilution 16.7.2.3.5. Broth Dilution 16.7.2.3.6. Genotyping Method 16.7.2.3.7. Others 16.7.2.4. UAE Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Application 16.7.2.4.1. Clinical Diagnostics 16.7.2.4.2. Drug Discovery and Development 16.7.2.4.3. Epidemiology 16.7.2.4.4. Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring) 16.7.2.5. UAE Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By End User 16.7.2.5.1. Hospitals and Diagnostic Centers 16.7.2.5.2. Pharmaceutical and Biotechnology Companies 16.7.2.5.3. Research and Academic Institutes 16.7.2.5.4. Clinical Research Organizations (CROs) 16.7.3. Egypt 16.7.3.1. Egypt Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Product 16.7.3.1.1. Manual Antimicrobial Susceptibility Testing 16.7.3.1.1.1. Susceptibility Testing Disks 16.7.3.1.1.2. MIC Strips 16.7.3.1.1.3. Susceptibility Testing Plates 16.7.3.1.2. Automated Antimicrobial Susceptibility Testing 16.7.3.1.3. Culture and Growth Media 16.7.3.1.4. Consumables 16.7.3.2. Egypt Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Type 16.7.3.2.1. Antibacterial Susceptibility Testing 16.7.3.2.2. Antifungal Susceptibility Testing 16.7.3.2.3. Antiparasitic Susceptibility Testing 16.7.3.2.4. Other Susceptibility Testing Types (slow-growing pathogens) 16.7.3.3. Egypt Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Method 16.7.3.3.1. Etest Method 16.7.3.3.2. Disk Diffusion 16.7.3.3.3. Automated Susceptibility Testing Instruments 16.7.3.3.4. Agar Dilution 16.7.3.3.5. Broth Dilution 16.7.3.3.6. Genotyping Method 16.7.3.3.7. Others 16.7.3.4. Egypt Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Application 16.7.3.4.1. Clinical Diagnostics 16.7.3.4.2. Drug Discovery and Development 16.7.3.4.3. Epidemiology 16.7.3.4.4. Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring) 16.7.3.5. Egypt Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By End User 16.7.3.5.1. Hospitals and Diagnostic Centers 16.7.3.5.2. Pharmaceutical and Biotechnology Companies 16.7.3.5.3. Research and Academic Institutes 16.7.3.5.4. Clinical Research Organizations (CROs) 16.7.4. Kuwait 16.7.4.1. Kuwait Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Product 16.7.4.1.1. Manual Antimicrobial Susceptibility Testing 16.7.4.1.1.1. Susceptibility Testing Disks 16.7.4.1.1.2. MIC Strips 16.7.4.1.1.3. Susceptibility Testing Plates 16.7.4.1.2. Automated Antimicrobial Susceptibility Testing 16.7.4.1.3. Culture and Growth Media 16.7.4.1.4. Consumables 16.7.4.2. Kuwait Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Type 16.7.4.2.1. Antibacterial Susceptibility Testing 16.7.4.2.2. Antifungal Susceptibility Testing 16.7.4.2.3. Antiparasitic Susceptibility Testing 16.7.4.2.4. Other Susceptibility Testing Types (slow-growing pathogens) 16.7.4.3. Kuwait Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Method 16.7.4.3.1. Etest Method 16.7.4.3.2. Disk Diffusion 16.7.4.3.3. Automated Susceptibility Testing Instruments 16.7.4.3.4. Agar Dilution 16.7.4.3.5. Broth Dilution 16.7.4.3.6. Genotyping Method 16.7.4.3.7. Others 16.7.4.4. Kuwait Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Application 16.7.4.4.1. Clinical Diagnostics 16.7.4.4.2. Drug Discovery and Development 16.7.4.4.3. Epidemiology 16.7.4.4.4. Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring) 16.7.4.5. Kuwait Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By End User 16.7.4.5.1. Hospitals and Diagnostic Centers 16.7.4.5.2. Pharmaceutical and Biotechnology Companies 16.7.4.5.3. Research and Academic Institutes 16.7.4.5.4. Clinical Research Organizations (CROs) 16.7.5. South Africa 16.7.5.1. South Africa Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Product 16.7.5.1.1. Manual Antimicrobial Susceptibility Testing 16.7.5.1.1.1. Susceptibility Testing Disks 16.7.5.1.1.2. MIC Strips 16.7.5.1.1.3. Susceptibility Testing Plates 16.7.5.1.2. Automated Antimicrobial Susceptibility Testing 16.7.5.1.3. Culture and Growth Media 16.7.5.1.4. Consumables 16.7.5.2. South Africa Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Type 16.7.5.2.1. Antibacterial Susceptibility Testing 16.7.5.2.2. Antifungal Susceptibility Testing 16.7.5.2.3. Antiparasitic Susceptibility Testing 16.7.5.2.4. Other Susceptibility Testing Types (slow-growing pathogens) 16.7.5.3. South Africa Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Method 16.7.5.3.1. Etest Method 16.7.5.3.2. Disk Diffusion 16.7.5.3.3. Automated Susceptibility Testing Instruments 16.7.5.3.4. Agar Dilution 16.7.5.3.5. Broth Dilution 16.7.5.3.6. Genotyping Method 16.7.5.3.7. Others 16.7.5.4. South Africa Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Application 16.7.5.4.1. Clinical Diagnostics 16.7.5.4.2. Drug Discovery and Development 16.7.5.4.3. Epidemiology 16.7.5.4.4. Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring) 16.7.5.5. South Africa Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By End User 16.7.5.5.1. Hospitals and Diagnostic Centers 16.7.5.5.2. Pharmaceutical and Biotechnology Companies 16.7.5.5.3. Research and Academic Institutes 16.7.5.5.4. Clinical Research Organizations (CROs) 16.7.6. Rest of Middle East & Africa 16.7.6.1. Rest of Middle East & Africa Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Product 16.7.6.1.1. Manual Antimicrobial Susceptibility Testing 16.7.6.1.1.1. Susceptibility Testing Disks 16.7.6.1.1.2. MIC Strips 16.7.6.1.1.3. Susceptibility Testing Plates 16.7.6.1.2. Automated Antimicrobial Susceptibility Testing 16.7.6.1.3. Culture and Growth Media 16.7.6.1.4. Consumables 16.7.6.2. Rest of Middle East & Africa Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Type 16.7.6.2.1. Antibacterial Susceptibility Testing 16.7.6.2.2. Antifungal Susceptibility Testing 16.7.6.2.3. Antiparasitic Susceptibility Testing 16.7.6.2.4. Other Susceptibility Testing Types (slow-growing pathogens) 16.7.6.3. Rest of Middle East & Africa Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Method 16.7.6.3.1. Etest Method 16.7.6.3.2. Disk Diffusion 16.7.6.3.3. Automated Susceptibility Testing Instruments 16.7.6.3.4. Agar Dilution 16.7.6.3.5. Broth Dilution 16.7.6.3.6. Genotyping Method 16.7.6.3.7. Others 16.7.6.4. Rest of Middle East & Africa Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Application 16.7.6.4.1. Clinical Diagnostics 16.7.6.4.2. Drug Discovery and Development 16.7.6.4.3. Epidemiology 16.7.6.4.4. Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring) 16.7.6.5. Rest of Middle East & Africa Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By End User 16.7.6.5.1. Hospitals and Diagnostic Centers 16.7.6.5.2. Pharmaceutical and Biotechnology Companies 16.7.6.5.3. Research and Academic Institutes 16.7.6.5.4. Clinical Research Organizations (CROs) 16.8. Key Segment for Channeling Investments 16.8.1. By Country 16.8.2. By Product 16.8.3. By Type 16.8.4. By Method 16.8.5. By Application 16.8.6. By End User 17. Latin America Antimicrobial Susceptibility Test Market Analysis and Forecasts, 2022 - 2030 17.1. Overview 17.1.1. Latin America Antimicrobial Susceptibility Test Market Revenue (US$ Mn) 17.2. Latin America Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Product 17.2.1. Manual Antimicrobial Susceptibility Testing 17.2.1.1. Susceptibility Testing Disks 17.2.1.2. MIC Strips 17.2.1.3. Susceptibility Testing Plates 17.2.2. Automated Antimicrobial Susceptibility Testing 17.2.3. Culture and Growth Media 17.2.4. Consumables 17.3. Latin America Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Type 17.3.1. Antibacterial Susceptibility Testing 17.3.2. Antifungal Susceptibility Testing 17.3.3. Antiparasitic Susceptibility Testing 17.3.4. Other Susceptibility Testing Types (slow-growing pathogens) 17.4. Latin America Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Method 17.4.1. Etest Method 17.4.2. Disk Diffusion 17.4.3. Automated Susceptibility Testing Instruments 17.4.4. Agar Dilution 17.4.5. Broth Dilution 17.4.6. Genotyping Method 17.4.7. Others 17.5. Latin America Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Application 17.5.1. Clinical Diagnostics 17.5.2. Drug Discovery and Development 17.5.3. Epidemiology 17.5.4. Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring) 17.6. Latin America Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By End User 17.6.1. Hospitals and Diagnostic Centers 17.6.2. Pharmaceutical and Biotechnology Companies 17.6.3. Research and Academic Institutes 17.6.4. Clinical Research Organizations (CROs) 17.7. Latin America Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Country 17.7.1. Brazil 17.7.1.1. Brazil Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Product 17.7.1.1.1. Manual Antimicrobial Susceptibility Testing 17.7.1.1.1.1. Susceptibility Testing Disks 17.7.1.1.1.2. MIC Strips 17.7.1.1.1.3. Susceptibility Testing Plates 17.7.1.1.2. Automated Antimicrobial Susceptibility Testing 17.7.1.1.3. Culture and Growth Media 17.7.1.1.4. Consumables 17.7.1.2. Brazil Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Type 17.7.1.2.1. Antibacterial Susceptibility Testing 17.7.1.2.2. Antifungal Susceptibility Testing 17.7.1.2.3. Antiparasitic Susceptibility Testing 17.7.1.2.4. Other Susceptibility Testing Types (slow-growing pathogens) 17.7.1.3. Brazil Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Method 17.7.1.3.1. Etest Method 17.7.1.3.2. Disk Diffusion 17.7.1.3.3. Automated Susceptibility Testing Instruments 17.7.1.3.4. Agar Dilution 17.7.1.3.5. Broth Dilution 17.7.1.3.6. Genotyping Method 17.7.1.3.7. Others 17.7.1.4. Brazil Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Application 17.7.1.4.1. Clinical Diagnostics 17.7.1.4.2. Drug Discovery and Development 17.7.1.4.3. Epidemiology 17.7.1.4.4. Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring) 17.7.1.5. Brazil Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By End User 17.7.1.5.1. Hospitals and Diagnostic Centers 17.7.1.5.2. Pharmaceutical and Biotechnology Companies 17.7.1.5.3. Research and Academic Institutes 17.7.1.5.4. Clinical Research Organizations (CROs) 17.7.2. Argentina 17.7.2.1. Argentina Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Product 17.7.2.1.1. Manual Antimicrobial Susceptibility Testing 17.7.2.1.1.1. Susceptibility Testing Disks 17.7.2.1.1.2. MIC Strips 17.7.2.1.1.3. Susceptibility Testing Plates 17.7.2.1.2. Automated Antimicrobial Susceptibility Testing 17.7.2.1.3. Culture and Growth Media 17.7.2.1.4. Consumables 17.7.2.2. Argentina Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Type 17.7.2.2.1. Antibacterial Susceptibility Testing 17.7.2.2.2. Antifungal Susceptibility Testing 17.7.2.2.3. Antiparasitic Susceptibility Testing 17.7.2.2.4. Other Susceptibility Testing Types (slow-growing pathogens) 17.7.2.3. Argentina Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Method 17.7.2.3.1. Etest Method 17.7.2.3.2. Disk Diffusion 17.7.2.3.3. Automated Susceptibility Testing Instruments 17.7.2.3.4. Agar Dilution 17.7.2.3.5. Broth Dilution 17.7.2.3.6. Genotyping Method 17.7.2.3.7. Others 17.7.2.4. Argentina Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Application 17.7.2.4.1. Clinical Diagnostics 17.7.2.4.2. Drug Discovery and Development 17.7.2.4.3. Epidemiology 17.7.2.4.4. Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring) 17.7.2.5. Argentina Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By End User 17.7.2.5.1. Hospitals and Diagnostic Centers 17.7.2.5.2. Pharmaceutical and Biotechnology Companies 17.7.2.5.3. Research and Academic Institutes 17.7.2.5.4. Clinical Research Organizations (CROs) 17.7.3. Rest of Latin America 17.7.3.1. Rest of Latin America Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Product 17.7.3.1.1. Manual Antimicrobial Susceptibility Testing 17.7.3.1.1.1. Susceptibility Testing Disks 17.7.3.1.1.2. MIC Strips 17.7.3.1.1.3. Susceptibility Testing Plates 17.7.3.1.2. Automated Antimicrobial Susceptibility Testing 17.7.3.1.3. Culture and Growth Media 17.7.3.1.4. Consumables 17.7.3.2. Rest of Latin America Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Type 17.7.3.2.1. Antibacterial Susceptibility Testing 17.7.3.2.2. Antifungal Susceptibility Testing 17.7.3.2.3. Antiparasitic Susceptibility Testing 17.7.3.2.4. Other Susceptibility Testing Types (slow-growing pathogens) 17.7.3.3. Rest of Latin America Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Method 17.7.3.3.1. Etest Method 17.7.3.3.2. Disk Diffusion 17.7.3.3.3. Automated Susceptibility Testing Instruments 17.7.3.3.4. Agar Dilution 17.7.3.3.5. Broth Dilution 17.7.3.3.6. Genotyping Method 17.7.3.3.7. Others 17.7.3.4. Rest of Latin America Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By Application 17.7.3.4.1. Clinical Diagnostics 17.7.3.4.2. Drug Discovery and Development 17.7.3.4.3. Epidemiology 17.7.3.4.4. Other Applications (Research and academic applications, bioterrorism surveillance, and environmental monitoring) 17.7.3.5. Rest of Latin America Antimicrobial Susceptibility Test Market Revenue (US$ Mn) and Forecasts, By End User 17.7.3.5.1. Hospitals and Diagnostic Centers 17.7.3.5.2. Pharmaceutical and Biotechnology Companies 17.7.3.5.3. Research and Academic Institutes 17.7.3.5.4. Clinical Research Organizations (CROs) 17.8. Key Segment for Channeling Investments 17.8.1. By Country 17.8.2. By Product 17.8.3. By Type 17.8.4. By Method 17.8.5. By Application 17.8.6. By End User 18. Competitive Benchmarking 18.1. Brand Benchmarking 18.2. Market Share Analysis, 2020 18.3. Global Presence and Growth Strategies 18.3.1. Mergers and Acquisitions 18.3.2. Product Launches 18.3.3. Investments Trends 18.3.4. R&D Initiatives 19. Player Profiles 19.1. Accelerate Diagnostics, Inc. 19.1.1. Company Details 19.1.2. Company Overview 19.1.3. Product Offerings 19.1.4. Key Developments 19.1.5. Financial Analysis 19.1.6. SWOT Analysis 19.1.7. Business Strategies 19.2. Alifax S.r.l. 19.2.1. Company Details 19.2.2. Company Overview 19.2.3. Product Offerings 19.2.4. Key Developments 19.2.5. Financial Analysis 19.2.6. SWOT Analysis 19.2.7. Business Strategies 19.3. Becton, Dickinson and Company 19.3.1. Company Details 19.3.2. Company Overview 19.3.3. Product Offerings 19.3.4. Key Developments 19.3.5. Financial Analysis 19.3.6. SWOT Analysis 19.3.7. Business Strategies 19.4. Bioanalyse 19.4.1. Company Details 19.4.2. Company Overview 19.4.3. Product Offerings 19.4.4. Key Developments 19.4.5. Financial Analysis 19.4.6. SWOT Analysis 19.4.7. Business Strategies 19.5. bioMérieux SA 19.5.1. Company Details 19.5.2. Company Overview 19.5.3. Product Offerings 19.5.4. Key Developments 19.5.5. Financial Analysis 19.5.6. SWOT Analysis 19.5.7. Business Strategies 19.6. Bio-Rad Laboratories, Inc. 19.6.1. Company Details 19.6.2. Company Overview 19.6.3. Product Offerings 19.6.4. Key Developments 19.6.5. Financial Analysis 19.6.6. SWOT Analysis 19.6.7. Business Strategies 19.7. Biotron Ltd 19.7.1. Company Details 19.7.2. Company Overview 19.7.3. Product Offerings 19.7.4. Key Developments 19.7.5. Financial Analysis 19.7.6. SWOT Analysis 19.7.7. Business Strategies 19.8. Bruker 19.8.1. Company Details 19.8.2. Company Overview 19.8.3. Product Offerings 19.8.4. Key Developments 19.8.5. Financial Analysis 19.8.6. SWOT Analysis 19.8.7. Business Strategies 19.9. CONDALAB 19.9.1. Company Details 19.9.2. Company Overview 19.9.3. Product Offerings 19.9.4. Key Developments 19.9.5. Financial Analysis 19.9.6. SWOT Analysis 19.9.7. Business Strategies 19.10. Creative Diagnostics 19.10.1. Company Details 19.10.2. Company Overview 19.10.3. Product Offerings 19.10.4. Key Developments 19.10.5. Financial Analysis 19.10.6. SWOT Analysis 19.10.7. Business Strategies 19.11. Danaher Corporation 19.11.1. Company Details 19.11.2. Company Overview 19.11.3. Product Offerings 19.11.4. Key Developments 19.11.5. Financial Analysis 19.11.6. SWOT Analysis 19.11.7. Business Strategies 19.12. ELITechGroup 19.12.1. Company Details 19.12.2. Company Overview 19.12.3. Product Offerings 19.12.4. Key Developments 19.12.5. Financial Analysis 19.12.6. SWOT Analysis 19.12.7. Business Strategies 19.13. Genefluidics, Inc. 19.13.1. Company Details 19.13.2. Company Overview 19.13.3. Product Offerings 19.13.4. Key Developments 19.13.5. Financial Analysis 19.13.6. SWOT Analysis 19.13.7. Business Strategies 19.14. Hi-Media Laboratories 19.14.1. Company Details 19.14.2. Company Overview 19.14.3. Product Offerings 19.14.4. Key Developments 19.14.5. Financial Analysis 19.14.6. SWOT Analysis 19.14.7. Business Strategies 19.15. InvivoGen 19.15.1. Company Details 19.15.2. Company Overview 19.15.3. Product Offerings 19.15.4. Key Developments 19.15.5. Financial Analysis 19.15.6. SWOT Analysis 19.15.7. Business Strategies 19.16. Liofilchem S.r.l. 19.16.1. Company Details 19.16.2. Company Overview 19.16.3. Product Offerings 19.16.4. Key Developments 19.16.5. Financial Analysis 19.16.6. SWOT Analysis 19.16.7. Business Strategies 19.17. Mast Group Ltd. 19.17.1. Company Details 19.17.2. Company Overview 19.17.3. Product Offerings 19.17.4. Key Developments 19.17.5. Financial Analysis 19.17.6. SWOT Analysis 19.17.7. Business Strategies 19.18. Merck KGaA 19.18.1. Company Details 19.18.2. Company Overview 19.18.3. Product Offerings 19.18.4. Key Developments 19.18.5. Financial Analysis 19.18.6. SWOT Analysis 19.18.7. Business Strategies 19.19. MP Biomedicals 19.19.1. Company Details 19.19.2. Company Overview 19.19.3. Product Offerings 19.19.4. Key Developments 19.19.5. Financial Analysis 19.19.6. SWOT Analysis 19.19.7. Business Strategies 19.20. PML Microbiologicals Inc. 19.20.1. Company Details 19.20.2. Company Overview 19.20.3. Product Offerings 19.20.4. Key Developments 19.20.5. Financial Analysis 19.20.6. SWOT Analysis 19.20.7. Business Strategies 19.21. QuantaMatrix Inc. 19.21.1. Company Details 19.21.2. Company Overview 19.21.3. Product Offerings 19.21.4. Key Developments 19.21.5. Financial Analysis 19.21.6. SWOT Analysis 19.21.7. Business Strategies 19.22. Roche Diagnostics Limited 19.22.1. Company Details 19.22.2. Company Overview 19.22.3. Product Offerings 19.22.4. Key Developments 19.22.5. Financial Analysis 19.22.6. SWOT Analysis 19.22.7. Business Strategies 19.23. Synbiosis 19.23.1. Company Details 19.23.2. Company Overview 19.23.3. Product Offerings 19.23.4. Key Developments 19.23.5. Financial Analysis 19.23.6. SWOT Analysis 19.23.7. Business Strategies 19.24. Thermo Fisher Scientific 19.24.1. Company Details 19.24.2. Company Overview 19.24.3. Product Offerings 19.24.4. Key Developments 19.24.5. Financial Analysis 19.24.6. SWOT Analysis 19.24.7. Business Strategies 19.25. ZHUHAI DL BIOTECH Co., Ltd. 19.25.1. Company Details 19.25.2. Company Overview 19.25.3. Product Offerings 19.25.4. Key Developments 19.25.5. Financial Analysis 19.25.6. SWOT Analysis 19.25.7. Business Strategies 19.26. Other Market Participants 20. Key Findings Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion. **Exclusive for Multi-User and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.